Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage

Hydralazine is a potent vasodilating medication used as adjunctive therapy for the treatment of hypertension. Rarely, hydralazine may cause the development of antineutrophil cytoplasmic antibody vasculitis with the pulmonary-renal syndrome. We are presenting a case of hydralazine-associated vasculit...

Descripción completa

Detalles Bibliográficos
Autores principales: Strubchevska, Kateryna, Kozyk, Marko, Jacobs, Matthew R, White, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168634/
https://www.ncbi.nlm.nih.gov/pubmed/37182038
http://dx.doi.org/10.7759/cureus.37332
_version_ 1785038890707451904
author Strubchevska, Kateryna
Kozyk, Marko
Jacobs, Matthew R
White, David
author_facet Strubchevska, Kateryna
Kozyk, Marko
Jacobs, Matthew R
White, David
author_sort Strubchevska, Kateryna
collection PubMed
description Hydralazine is a potent vasodilating medication used as adjunctive therapy for the treatment of hypertension. Rarely, hydralazine may cause the development of antineutrophil cytoplasmic antibody vasculitis with the pulmonary-renal syndrome. We are presenting a case of hydralazine-associated vasculitis and pulmonary hemorrhage. 
format Online
Article
Text
id pubmed-10168634
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101686342023-05-10 Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage Strubchevska, Kateryna Kozyk, Marko Jacobs, Matthew R White, David Cureus Cardiology Hydralazine is a potent vasodilating medication used as adjunctive therapy for the treatment of hypertension. Rarely, hydralazine may cause the development of antineutrophil cytoplasmic antibody vasculitis with the pulmonary-renal syndrome. We are presenting a case of hydralazine-associated vasculitis and pulmonary hemorrhage.  Cureus 2023-04-09 /pmc/articles/PMC10168634/ /pubmed/37182038 http://dx.doi.org/10.7759/cureus.37332 Text en Copyright © 2023, Strubchevska et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Strubchevska, Kateryna
Kozyk, Marko
Jacobs, Matthew R
White, David
Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
title Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
title_full Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
title_fullStr Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
title_full_unstemmed Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
title_short Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
title_sort hydralazine-associated vasculitis and pulmonary hemorrhage
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168634/
https://www.ncbi.nlm.nih.gov/pubmed/37182038
http://dx.doi.org/10.7759/cureus.37332
work_keys_str_mv AT strubchevskakateryna hydralazineassociatedvasculitisandpulmonaryhemorrhage
AT kozykmarko hydralazineassociatedvasculitisandpulmonaryhemorrhage
AT jacobsmatthewr hydralazineassociatedvasculitisandpulmonaryhemorrhage
AT whitedavid hydralazineassociatedvasculitisandpulmonaryhemorrhage

Ejemplares similares